Get started
Author

Urja Desai

Observed name: UrjaN Desai
Institution: Gujarat University
ORCID: 0000-0003-1509-935X
Observed ORCID: 0000-0003-1509-935X
OpenAlex ID: A5105512174
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
2015 · Krupa Shah, Sheefa Mirza, et al. · Anti-Cancer Agents in Medicinal Chemistry · 37
Enhancement of the cytotoxic effects of Cytarabine in synergism with Hesperidine and Silibinin in Acute Myeloid Leukemia: An in-vitro approach
2015 · RakeshM Rawal, UrjaN Desai, et al. · Journal of Cancer Research and Therapeutics · 35
EGFR Mutation Analysis in Non-small Cell Lung Carcinoma Patients: A Liquid Biopsy Approach
2019 · Jigna Joshi, Apexa Raval, et al. · Indian Journal of Clinical Biochemistry · 9
Modulation of drug resistance in leukemia using phytochemicals: an in-silico, in-vitro, and in-vivo approach
2023 · Urja Desai, Medha Pandya, et al. · Elsevier eBooks · 6
Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer
2023 · Esha Joshi, Medha Pandya, et al. · Current Protein and Peptide Science · 5
Role of epithelial - Stromal interaction protein-1 expression in breast cancer
2020 · FrankyD Shah, ApexaP Raval, et al. · Indian Journal of Pathology and Microbiology · 5
Abstract 91: Molecular insight into drug resistance in acute myeloid leukemia: An in-silico and in-vitro approach
2017 · Urja Desai, Sheefa Mirza, et al. · Cancer Research · 5
Identification of the Novel HLA‐C*04:562 Allele in an Individual From Gujarat, India
2026 · Sunita Bhavsar, Urja Desai, et al. · HLA · 4
PDF
Hedgehog Signaling: An emerging targeting therapy in Cancer
2018 · Hitarth Patel, Jigna Joshi, et al. · Asian Journal of Pharmacy and Pharmacology · 4
PDF
Integrative network pharmacology and molecular simulation approach unveils the multi-pathway therapeutic mechanism of Curcumin, Withaferin A, and andrographolide against acute Myeloid Leukemia
2026 · Riya Vaghela, Nandan Dixit, et al. · In Silico Research in Biomedicine · 3
Identification of the HLA ‐C*18:06 Allele in a Prospective Bone Marrow Donor
2025 · Sunita Bhavsar, Akshay Chaudhary, et al. · HLA · 3
Pelargonidin-3,5-diglucoside found in Pomegranate aril acts as a potent HIF-1α inhibitor in in-silico study
2023 · Esha Joshi, Medha Pandya, et al. · Research Square · 2
PDF
Multimodality Testing of Her2/neu Marker in Breast Cancer: a Correlative Study
2022 · Shilpa Balar, Esha Joshi, et al. · Towards Excellence · 2
Carbon Nanobots as Biosensors for Infectious Diseases
2024 · Medha Pandya, Urja Desai, et al. · CRC Press eBooks · 1
Multimodal molecular profiling of invasive ductal carcinoma: High concordance of qPCR with FISH in HER2 assessment and exomic landscape of high-risk subtypes
2026 · Shilpa Balar, Esha Joshi, et al. · Pathology - Research and Practice
Metabolic Reprogramming in Cancer and Therapeutic Implications
2026 · Sapna Singh, Urja Desai, et al. · Springer eBooks
Cytological and biochemical correlation of ascitic fluid with clinical features in a tertiary care center
2025 · Aishani Tiwari, Ankitaben Vasantkumar Pandya, et al. · IP Archives of Cytology and Histopathology Research
PDF
Comparative Analysis of Clinical and Molecular Characteristics in Invasive Ductal Carcinoma of the Breast
2023 · Shilpa Balar, Esha Joshi, et al. · Research Square
PDF
Works count: 19
Citation count: 121
H-index: 5
I10-index: 2
Year
Topic
Type